104 related articles for article (PubMed ID: 2502424)
1. Plasma glycosyltransferase activity after ABO-incompatible bone marrow transplantation and development of an inhibitor for glycosyltransferase activity.
Matsue K; Yasue S; Matsuda T; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Koizumi S
Exp Hematol; 1989 Aug; 17(7):827-31. PubMed ID: 2502424
[TBL] [Abstract][Full Text] [Related]
2. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
3. A new concept of accommodation in ABO-incompatible kidney transplantation.
Takahashi K
Clin Transplant; 2005; 19 Suppl 14():76-85. PubMed ID: 15955174
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
5. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
6. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
[TBL] [Abstract][Full Text] [Related]
7. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
8. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
Ito M; Imoto S; Nakagawa T; Kai S; Hara H
Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
[TBL] [Abstract][Full Text] [Related]
9. [ABO-incompatible allogeneic bone marrow transplantation].
Xu L; Guo N; Wang S
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
[TBL] [Abstract][Full Text] [Related]
11. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
12. Presence of an inhibitor of glycosyltransferase activity in a patient following an ABO incompatible liver transplant.
Barbolla L; Mojena M; Cienfuegos JA; Escartín P
Br J Haematol; 1988 May; 69(1):93-6. PubMed ID: 3132966
[TBL] [Abstract][Full Text] [Related]
13. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
[TBL] [Abstract][Full Text] [Related]
14. [Delay in red blood cell recovery after major ABO incompatible bone marrow transplantation].
Fukuda M; Matsumoto K; Kojima S; Matsuyama T; Maeda H; Akatsuka Y; Tsuzuki S; Sughara T; Minami S; Kodera Y
Rinsho Ketsueki; 1991 Jan; 32(1):24-8. PubMed ID: 2020113
[TBL] [Abstract][Full Text] [Related]
15. Use of the gel test to follow up chimerism in ABO mismatched bone marrow transplantation patient: a case report.
Lumkul R; Nathalang O; Arnutti P; Janyatham A; Torcharus K; Krutvecheo T; Sriphaisal T
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S311-6. PubMed ID: 16858974
[TBL] [Abstract][Full Text] [Related]
16. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
[TBL] [Abstract][Full Text] [Related]
18. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
[TBL] [Abstract][Full Text] [Related]
19. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
[TBL] [Abstract][Full Text] [Related]
20. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
